Literature DB >> 16874807

Neurons and glial cells differentially express P2Y receptor mRNAs in the rat dorsal root ganglion and spinal cord.

Kimiko Kobayashi1, Tetsuo Fukuoka, Hiroki Yamanaka, Hirok Iyamanaka, Yi Dai, Koichi Obata, Atsushi Tokunaga, Koichi Noguchi.   

Abstract

We examined the precise distribution of mRNAs for six cloned rat P2Y receptor subtypes, P2Y1, P2Y2, P2Y4, P2Y6, P2Y12, and P2Y14, in the dorsal root ganglion (DRG) and spinal cord by in situ hybridization histochemistry (ISHH) with 35S-labeled riboprobes. In the DRG, P2Y1 and P2Y2 mRNAs were expressed by 15% and 24% of all neurons, respectively. Although each receptor was evenly distributed between neurofilament-positive and -negative neurons, P2Y2 was rather selectively expressed by TrkA-positive neurons. Schwann cells expressed P2Y2 mRNA, and the nonneuronal cells around the DRG neurons, perhaps the satellite cells, expressed P2Y12 and P2Y14 mRNAs. No ISHH signals for P2Y4 or P2Y6 were seen in any cellular components of the DRG. In the spinal cord, P2Y1 and P2Y4 mRNAs were expressed by some of the dorsal horn neurons, whereas the motor neurons in the ventral horn had P2Y4 and P2Y6 mRNAs. In addition, astrocytes in the gray matter had P2Y1 mRNA, and the microglia throughout the spinal cord expressed P2Y12 mRNA. P2Y14 mRNA was weakly expressed by putative microglia. These findings should provide useful information in interpreting pharmacological and electrophysiological studies in this field given the lack of highly selective antagonists for each P2Y receptor subtype. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16874807     DOI: 10.1002/cne.21066

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  56 in total

1.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

Review 2.  Signalling and pharmacological properties of the P2Y receptor.

Authors:  T K Harden; J I Sesma; I P Fricks; E R Lazarowski
Journal:  Acta Physiol (Oxf)       Date:  2010-03-24       Impact factor: 6.311

3.  Expression of purinergic receptor P2Y4 in Schwann cell following nerve regeneration.

Authors:  Shicai Chen; Siwen Xia; Yue Sun; Meng Li; Xianmin Song; Guojun Li; Hongliang Zheng; Donghui Chen
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  P2Y14 Receptor Antagonists Reverse Chronic Neuropathic Pain in a Mouse Model.

Authors:  Fatma Mufti; Young-Hwan Jung; Luigino Antonio Giancotti; Jinha Yu; Zhoumou Chen; Ngan B Phung; Kenneth A Jacobson; Daniela Salvemini
Journal:  ACS Med Chem Lett       Date:  2020-04-30       Impact factor: 4.345

5.  Deletion of the murine ATP/UTP receptor P2Y2 alters mechanical and thermal response properties in polymodal cutaneous afferents.

Authors:  Derek C Molliver; Kristofer K Rau; Michael P Jankowski; Deepak J Soneji; Kyle M Baumbauer; H Richard Koerber
Journal:  Neuroscience       Date:  2016-07-05       Impact factor: 3.590

Review 6.  P2X receptor channels in chronic pain pathways.

Authors:  Louis-Philippe Bernier; Ariel R Ase; Philippe Séguéla
Journal:  Br J Pharmacol       Date:  2017-08-17       Impact factor: 8.739

Review 7.  Nucleotide signaling and cutaneous mechanisms of pain transduction.

Authors:  G Dussor; H R Koerber; A L Oaklander; F L Rice; D C Molliver
Journal:  Brain Res Rev       Date:  2008-12-31

8.  Satellite glial cells in the trigeminal ganglion as a determinant of orofacial neuropathic pain.

Authors:  Jean-Philippe Vit; Luc Jasmin; Aditi Bhargava; Peter T Ohara
Journal:  Neuron Glia Biol       Date:  2006-11

9.  Glutamate-mediated astrocyte-to-neuron signalling in the rat dorsal horn.

Authors:  Rita Bardoni; Alessia Ghirri; Micaela Zonta; Chiara Betelli; Giovanni Vitale; Valentina Ruggieri; Maurizio Sandrini; Giorgio Carmignoto
Journal:  J Physiol       Date:  2010-01-18       Impact factor: 5.182

10.  Thrombin-promoted release of UDP-glucose from human astrocytoma cells.

Authors:  S M Kreda; L Seminario-Vidal; C van Heusden; E R Lazarowski
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.